Clinical trials, adaptability and the COVID-19 pandemic

Ramez N. Eskander, Bhavana Pothuri, Leslie Randall, David O'Malley, Brian Slomovitz, Kathleen Moore, Robert Coleman, Thomas Herzog, Bradley J. Monk, Larry Copeland

Research output: Contribution to journalArticlepeer-review

Abstract

Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.

Original languageEnglish (US)
Article number100680
JournalGynecologic Oncology Reports
Volume35
DOIs
StatePublished - Feb 2021
Externally publishedYes

Keywords

  • Adaptability
  • COVID-19
  • Clinical trials
  • Gynecologic cancer
  • Pandemic

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Clinical trials, adaptability and the COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this